Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet Income
Growth Metrics
Income Statement
Others
Ratios

CureVac (CVAC) Free Cash Flow (2020 - 2025)

Historic Free Cash Flow for CureVac (CVAC) over the last 6 years, with Q3 2025 value amounting to $35.2 million.

  • CureVac's Free Cash Flow fell 9103.33% to $35.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$153.6 million, marking a year-over-year decrease of 37182.41%. This contributed to the annual value of $93.5 million for FY2024, which is 12715.07% up from last year.
  • As of Q3 2025, CureVac's Free Cash Flow stood at $35.2 million, which was down 9103.33% from -$46.8 million recorded in Q2 2025.
  • In the past 5 years, CureVac's Free Cash Flow ranged from a high of $524.1 billion in Q4 2021 and a low of -$299.4 billion during Q3 2021
  • Its 5-year average for Free Cash Flow is -$1.6 billion, with a median of -$92.3 million in 2024.
  • Per our database at Business Quant, CureVac's Free Cash Flow surged by 11263441.65% in 2021 and then crashed by 6881166.43% in 2022.
  • Quarter analysis of 5 years shows CureVac's Free Cash Flow stood at $524.1 billion in 2021, then crashed by 100.04% to -$208.4 million in 2022, then skyrocketed by 30.75% to -$144.3 million in 2023, then skyrocketed by 31.38% to -$99.0 million in 2024, then skyrocketed by 135.54% to $35.2 million in 2025.
  • Its last three reported values are $35.2 million in Q3 2025, -$46.8 million for Q2 2025, and -$43.0 million during Q1 2025.